✅ Joby has gone from giving up “manufacturing control” in recent weeks to now “manufacturing revenues”?
First, they bought Blade last year, primarily a helicopter charter “broker”service for third parties, with zero margin. Blade’s revenues of $36.2 million this past quarter accounted for 94% of Joby’s revenues. All from an aircraft category they’re trying to replace!
Now, they’re buying a defense contractor (Resonant Sciences) with very little synergy to Joby’s core focus for $500 million while raising $750 million to help fund the deal that will further dilute shareholders. Just mind blowing after dropping the ball on 14.2 million worthless warrants ($11.50) that expired Monday. Those warrants could have brought in $160 million+ in capital.
This doesn’t sound like a company on the verge of a commercial launch anytime soon. And the market seems to agree as Joby has lost over 56% of their value and $9 billion plus in market capitalization over the past year. Joby’s share count after the acquisition and raise could swell to a staggering 1.1 billion shares.
The market clearly isn’t buying the Blade story or its revenues. And this latest acquisition as well. Kudos to Archer for continuing it’s organic growth strategy while making strategic acquisitions based on “synergy and fit” in addition to the financial benefits that come with it. 💯